A. V. Timokhova

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Viral hepatitis C is a dangerous, widespread human disease. The choice of drugs for treatment of chronic hepatitis C virus (HCV) infection is limited, and prophylactic vaccines do not exist. Thus, the development of new antiviral strategies and substances is an issue of great importance. The targeting of viral morphogenesis might be used as an alternative(More)
  • 1